AN2 Therapeutics Inc (NASDAQ: ANTX) is -94.97% lower on its value in year-to-date trading and has touched a low of $0.87 and a high of $22.22 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ANTX stock was last observed hovering at around $1.03 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $1.03, the stock is -59.95% and -56.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.45 million and changing 0.00% at the moment leaves the stock -87.92% off its SMA200. ANTX registered -87.74% loss for a year compared to 6-month loss of -94.85%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -60.08% gain in the last 1 month and extending the period to 3 months gives it a -57.44%, and is -58.96% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.54% over the week and 11.24% over the month.
AN2 Therapeutics Inc (ANTX) has around 41 employees, a market worth around $30.72M and $0.00M in sales. Distance from 52-week low is 18.39% and -95.36% from its 52-week high. The company has generated returns on investments over the last 12 months (-59.70%).
The EPS is expected to grow by 18.61% this year.
AN2 Therapeutics Inc (ANTX) Top Institutional Holders
The shares outstanding are 29.74M, and float is at 19.98M with Short Float at 3.42%.
AN2 Therapeutics Inc (ANTX) Insider Activity
The most recent transaction is an insider sale by Zakrzewski Joseph S,the company’sDirector. SEC filings show that Zakrzewski Joseph S sold 100,000 shares of the company’s common stock on Jan 18 ’24 at a price of $19.11 per share for a total of $1.91 million. Following the sale, the insider now owns 0.41 million shares.
AN2 Therapeutics Inc disclosed in a document filed with the SEC on Jan 16 ’24 that Aziz Kabeer (Director) sold a total of 100,000 shares of the company’s common stock. The trade occurred on Jan 16 ’24 and was made at $19.65 per share for $1.97 million. Following the transaction, the insider now directly holds 0.38 million shares of the ANTX stock.
Still, SEC filings show that on Jan 16 ’24, Adjuvant Global Health Technol (10% Owner) disposed off 84,093 shares at an average price of $19.65 for $1.65 million. The insider now directly holds 1,995,958 shares of AN2 Therapeutics Inc (ANTX).
